These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8039247

  • 1. In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling.
    Flamand V, Donckier V, Abramowicz D, Goldman M, Vandenabeele P, Urbain J, Moser M, Leo O.
    Cell Immunol; 1994 Aug; 157(1):239-48. PubMed ID: 8039247
    [Abstract] [Full Text] [Related]

  • 2. Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions.
    Andris F, Van Mechelen M, De Mattia F, Baus E, Urbain J, Leo O.
    Eur J Immunol; 1996 May; 26(5):1187-95. PubMed ID: 8647186
    [Abstract] [Full Text] [Related]

  • 3. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA.
    J Immunol; 1989 Feb 01; 142(3):737-43. PubMed ID: 2521507
    [Abstract] [Full Text] [Related]

  • 4. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
    Vossen AC, Tibbe GJ, Kroos MJ, van de Winkel JG, Benner R, Savelkoul HF.
    Eur J Immunol; 1995 Jun 01; 25(6):1492-6. PubMed ID: 7614975
    [Abstract] [Full Text] [Related]

  • 5. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML, Tso JY, Sattar HA, Smith J, Desalle F, Cole M, Bluestone JA.
    J Immunol; 1995 Aug 01; 155(3):1544-55. PubMed ID: 7636216
    [Abstract] [Full Text] [Related]

  • 6. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J, Davis J, Bracht M, Carton J, Armstrong J, Gao W, Scallon B, Fung R, Emmell E, Zimmerman M, Griswold DE, Li L.
    Int Immunopharmacol; 2006 Jun 01; 6(6):880-91. PubMed ID: 16644473
    [Abstract] [Full Text] [Related]

  • 7. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
    Sawchuk SS, Gates R, Hirsch R.
    Transplantation; 1995 Dec 15; 60(11):1331-7. PubMed ID: 8525530
    [Abstract] [Full Text] [Related]

  • 8. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).
    Henrickson M, Reid J, Bellet JS, Sawchuk SS, Hirsch R.
    Transplantation; 1995 Oct 27; 60(8):828-35. PubMed ID: 7482743
    [Abstract] [Full Text] [Related]

  • 9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR, Taylor PA, Vallera DA.
    J Immunol; 1994 Apr 01; 152(7):3665-74. PubMed ID: 8144942
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
    Eto M, Yoshikai Y, Nishimura Y, Hiromatsu K, Maeda T, Nomoto K, Kong YY, Kubo RT, Kumazawa J, Nomoto K.
    Immunology; 1994 Feb 01; 81(2):198-204. PubMed ID: 8157269
    [Abstract] [Full Text] [Related]

  • 11. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.
    Bolt S, Routledge E, Lloyd I, Chatenoud L, Pope H, Gorman SD, Clark M, Waldmann H.
    Eur J Immunol; 1993 Feb 01; 23(2):403-11. PubMed ID: 8436176
    [Abstract] [Full Text] [Related]

  • 12. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L.
    Novartis Found Symp; 2003 Feb 01; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [Abstract] [Full Text] [Related]

  • 13. Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.
    Hirsch R, Bluestone JA, Bare CV, Gress RE.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):270-1. PubMed ID: 1824981
    [No Abstract] [Full Text] [Related]

  • 14. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets.
    Smith JA, Tang Q, Bluestone JA.
    J Immunol; 1998 May 15; 160(10):4841-9. PubMed ID: 9590231
    [Abstract] [Full Text] [Related]

  • 15. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P, de Ojeda G, Criado G, Fernández-Centeno E, Rojo JM.
    Cell Immunol; 1999 Aug 01; 195(2):96-109. PubMed ID: 10448009
    [Abstract] [Full Text] [Related]

  • 16. In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth.
    Hirsch R, Ellenhorn JD, Bluestone JA.
    Princess Takamatsu Symp; 1988 Aug 01; 19():237-43. PubMed ID: 2978618
    [Abstract] [Full Text] [Related]

  • 17. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
    Alegre ML, Peterson LJ, Xu D, Sattar HA, Jeyarajah DR, Kowalkowski K, Thistlethwaite JR, Zivin RA, Jolliffe L, Bluestone JA.
    Transplantation; 1994 Jun 15; 57(11):1537-43. PubMed ID: 8009586
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N, Revillard JP.
    J Heart Lung Transplant; 1996 May 15; 15(5):435-42. PubMed ID: 8771497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
    Hirsch R, Bluestone JA, DeNenno L, Gress RE.
    Transplantation; 1990 Jun 15; 49(6):1117-23. PubMed ID: 2141740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.